BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1381778)

  • 1. Cerebral vasodilating and spasmolytic actions of a new Ca-antagonist, clentiazem (TA-3090), in anesthetized animals.
    Murata S; Kikkawa K; Nagao T
    J Cardiovasc Pharmacol; 1992 May; 19(5):790-7. PubMed ID: 1381778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental studies of the effect of diltiazem (Ca-antagonist) on cerebral circulation and cerebral arterial spasm].
    Kyoi K; Yokoyama K; Tsukamoto M; Morimoto T; Sakaki T; Kinugawa K; Okazaki A; Utsumi S
    No To Shinkei; 1982 Dec; 34(12):1145-51. PubMed ID: 7159544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasodilating effects of the new calcium antagonist benidipine hydrochloride in anesthetized dogs and cats.
    Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1707-12. PubMed ID: 3219145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasodilator action of KB-944, a new calcium antagonist.
    Morita T; Yoshino K; Kanazawa T; Ito K; Nose T
    Arzneimittelforschung; 1982; 32(9):1037-42. PubMed ID: 6890822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral vasodilation and spasmolytic activity of diltiazem in anesthetized animals.
    Murata S; Nagao T; Nakajima H
    Jpn J Pharmacol; 1982 Dec; 32(6):1033-40. PubMed ID: 7161959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium antagonistic and spasmolytic activities of a new 1,5-benzothiazepine derivative in isolated canine and monkey arteries.
    Kikkawa K; Murata S; Nagao T
    Arzneimittelforschung; 1988 Apr; 38(4):526-31. PubMed ID: 3165267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
    Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of a new 1,5-benzothiazepine calcium antagonist in anesthetized dogs.
    Murata S; Kikkawa K; Yabana H; Nagao T
    Arzneimittelforschung; 1988 Apr; 38(4):521-5. PubMed ID: 3401267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the new calcium antagonist 2-nitratopropyl-3-nitratopropyl-2,6-dimethyl-4-(3-nitrophe nyl)- 1,4-dihydropyridine-3,5-dicarboxylate on cerebral circulation in dogs.
    Tsuchida K; Yamazaki R; Kaneko K; Aihara H
    Arzneimittelforschung; 1987 Nov; 37(11):1239-43. PubMed ID: 3481545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics and pharmacokinetics of clentiazem and diltiazem in closed-chest anesthetized dogs.
    Giasson S; Garceau D; Homsy W; Dumont L
    Cardiovasc Drugs Ther; 1995 Oct; 9(5):685-92. PubMed ID: 8573551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clentiazem and diltiazem preserve endothelium-dependent relaxation following global rat heart ischemia.
    Dagenais F; Hollmann C; Buluran J; Cartier R
    Can J Cardiol; 1995 Oct; 11(9):816-22. PubMed ID: 7585280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of clentiazem on arterial pressure and renal function in normotensive and hypertensive rats.
    Fenoy FJ; Milicic I; Mistry M; Mecca TE; Roman RJ
    J Pharmacol Exp Ther; 1992 May; 261(2):470-5. PubMed ID: 1578362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrovascular effects of YC-93, a new vasodilator, in dogs, monkeys and human patients.
    Takenaka T; Handa J
    Int J Clin Pharmacol Biopharm; 1979 Jan; 17(1):1-11. PubMed ID: 33121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clentiazem protects against chronic cerebral vasospasm in rabbit basilar artery.
    Vorkapic P; Bevan JA; Bevan RD
    Stroke; 1991 Nov; 22(11):1409-13. PubMed ID: 1750049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic effects of a new 1,5-benzothiazepine calcium antagonist on stroke in salt-loaded stroke-prone spontaneously hypertensive rats.
    Kikkawa K; Murata S; Iwasaki H; Toriumi W; Banno K; Nagao T
    Arzneimittelforschung; 1992 Jun; 42(6):781-6. PubMed ID: 1418031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral circulatory and cardiac effects of vinpocetine and its metabolite, apovincaminic acid, in anesthetized dogs.
    Imamoto T; Tanabe M; Shimamoto N; Kawazoe K; Hirata M
    Arzneimittelforschung; 1984; 34(2):161-9. PubMed ID: 6539108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracranial pressure during diltiazem-induced hypotension in anesthetized dogs.
    Mazzoni P; Giffin JP; Cottrell JE; Hartung J; Capuano C; Epstein JM
    Anesth Analg; 1985 Oct; 64(10):1001-4. PubMed ID: 4037378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of intravenous administration of diltiazem on cerebral blood flow and brain function].
    Konishi T; Handa H; Moritake K; Suwa H; Takaya M; Takebe Y
    No To Shinkei; 1985 Jun; 37(6):567-73. PubMed ID: 4041287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clentiazem given at reperfusion improves subendocardial reflow and reduces myocardial infarct size in the dog.
    Rousseau G; Provost P; Tran D; Caillé G; Latour JG
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1252-60. PubMed ID: 8138938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between the cardiovascular effects and both plasma and myocardial levels of clentiazem, a new benzothiazepine calcium antagonist, in anesthetized dogs.
    Valérie V; Louis D; Marc L; Denis G; Claude C; Gilles C
    Cardiovasc Drugs Ther; 1991 Dec; 5(6):997-1003. PubMed ID: 1801898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.